All Issueskureus.com
Issue #01 · March 14, 2026

The Weekly

Therapy

AI intelligence for pharma teams who'd rather lead than follow

This week: 5 stories shaping pharma AI

Lead Story

Microsoft declares war on fragmented health data

Launched at HIMSS26 on March 12, Copilot Health is Microsoft's most direct move yet into consumer health AI. It connects records from 50,000+ U.S. hospitals, 50+ wearables, and lab results — then applies AI to tell a coherent story of your health. Microsoft CEO of AI Mustafa Suleyman called it "the first steps towards a medical superintelligence."

For pharma, this matters: the patient is now arriving at the HCP consultation pre-informed, pre-analyzed, and ready to ask sharper questions. The commercial rep's brief needs to match that bar.

The real play isn't patient-facing. It's the underlying data interoperability layer. If Microsoft controls how health data flows between providers, it controls the infrastructure pharma needs for real-world evidence and post-market surveillance.

Source: Microsoft Industry Blog · March 12, 2026

02
Big Tech × Health

Amazon opens its health AI to 200M Prime members

On March 10, Amazon expanded Health AI — previously exclusive to One Medical members — to Amazon.com and its app. Built on Bedrock's multi-agent architecture, it books appointments, reads labs, renews prescriptions, and routes patients to care. No Prime required.

The AI is now embedded in the same surface where 300M+ people shop. The patient journey just got a new front door — and it belongs to Amazon.

Source: TechCrunch · March 10, 2026

03
AI Arms Race

ChatGPT Health vs. Claude for Healthcare — the race is live

Both products launched in January 2026 within one week of each other. OpenAI's ChatGPT Health delivers clinically grounded responses with EHR context. Anthropic's Claude for Healthcare positions on safety and interpretability for clinical workflows.

Three major players now offer health AI front-ends. The question for pharma: who owns the patient's first interaction — and what does that mean for brand relevance?

Source: OpenAI · January 7, 2026 / Anthropic · January 13, 2026

04
Pharma Intelligence

IQVIA: 2026 is the year AI stops analyzing and starts acting

IQVIA's latest perspective piece declares the "agentic shift" is here. AI in pharma moves from insight engine to active operator — executing medical writing, orchestrating field team workflows, and routing HCP engagement decisions autonomously.

Their GMI Agent, powered by NVIDIA, already covers 95 countries with real-time commercial intelligence in natural language. The pilot era is over.

Source: PharmaVoice · December 2025

05
Safety & Compliance

Agentic AI in pharmacovigilance: 40% capacity unlocked

IQVIA research shows agentic AI could release 25–40% of human capacity in safety operations while increasing operational efficiency by up to 5.4 percentage points.

Agents monitor transcripts, emails, and safety databases in real time — flagging high-risk cases directly to reviewers. For regulatory-heavy teams, this is the most actionable AI use case of 2026.

Source: HIT Consultant · January 15, 2026

The Therapy Session

The companies that win in pharma AI won't be the ones with the best models. They'll be the ones who figured out governance, validation, and change management first. The technology is the easy part.

The Weekly Therapy Editorial

From kureus

We build the first step.

Not a 200-slide strategy deck. A working AI workflow, deployed in your team, delivering measurable ROI in 3 weeks. That's how the best pharma companies start.

Book a 20-min diagnosis →

The Weekly Therapy · Issue #01 · © 2026 kureus